TOKENPOST
1 min read
Add as a preferred source on Google

Bolt Biotherapeutics Posts Q3 GAAP Loss of $2.25 Per Share

The Nasdaq-listed company trades under the symbol BOLT.

By John Kim
Published
NO STORY 관련 이미지 / TokenPost.ai
NO STORY 관련 이미지 / TokenPost.ai

Bolt Biotherapeutics, Inc. posted third-quarter GAAP earnings per share of -$2.25. The figure represents a loss of $2.25 per share.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…